A Vision for Patient-Centric Gene Therapy Development

Ben Yerxa, CEO of Opus Genetics, discusses the genesis of the company, its gene therapy pipeline, and what patient organizations looking to take a more hands-on approach to therapeutic development can learn from its example. @globalgenes #RARECast